Associate Director, Clinical Pharmacology and Pharmacometrics
Bristol Myers Squibb
Dr. Can Liu is an Associate Director at Bristol Myers Squibb, specializing in clinical pharmacokinetics and pharmacometrics. He was graduated from China Pharmaceutical University where he completed PhD research on Drug Metabolism and Pharmacokinetics. Dr. Liu undertook postdoctoral research in University of North Carolina at Chapel Hill, focusing on modeling and simulation in cancer immunotherapy. In his current role, Dr. Liu plays a key role in leading strategic decisions in clinical pharmacology and guiding pharmacokinetic modeling and dose optimization strategies for clinical trials, particularly in the early development of therapies for rare diseases and oncology indications. Dr. Can has authored numerous publications in peer-reviewed journals and regularly presents his work at conferences.